Vimal Mehta
2022
In 2022, Vimal Mehta earned a total compensation of $4.6M as Chief Executive Officer at BioXcel Therapeutics, a 51% decrease compared to previous year.
Compensation breakdown
| Bonus | $150,000 |
|---|---|
| Non-Equity Incentive Plan | $654,662 |
| Option Awards | $1,994,080 |
| Salary | $944,436 |
| Stock Awards | $800,592 |
| Other | $15,425 |
| Total | $4,559,195 |
Mehta received $2M in option awards, accounting for 44% of the total pay in 2022.
Mehta also received $150K in bonus, $654.7K in non-equity incentive plan, $944.4K in salary, $800.6K in stock awards and $15.4K in other compensation.
Rankings
In 2022, Vimal Mehta's compensation ranked 719th out of 5,736 executives tracked by ExecPay. In other words, Mehta earned more than 87.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 719 out of 5,736 | 88th |
Division Manufacturing | 317 out of 3,125 | 90th |
Major group Chemicals And Allied Products | 100 out of 1,416 | 93rd |
Industry group Drugs | 87 out of 1,317 | 93rd |
Industry Pharmaceutical Preparations | 66 out of 963 | 93rd |
Source: SEC filing on May 17, 2023.
Mehta's colleagues
We found two more compensation records of executives who worked with Vimal Mehta at BioXcel Therapeutics in 2022.
News
BioXcel Therapeutics CEO Vimal Mehta's 2023 pay rises 4% to $4.7M
April 29, 2024
BioXcel Therapeutics CEO Vimal Mehta's 2022 pay falls 51% to $4.6M
May 17, 2023
BioXcel Therapeutics CEO Vimal Mehta's 2021 pay slips 2% to $9.4M
April 5, 2022
BioXcel Therapeutics CEO Vimal Mehta's 2020 pay jumps 386% to $9.6M
April 27, 2021
BioXcel Therapeutics CEO Vimal Mehta's 2019 pay jumps 181% to $2M
April 6, 2020
BioXcel Therapeutics CEO Vimal Mehta's 2018 pay jumps 147% to $702K
April 1, 2019